Fred J. Roisen
Corporate Officer/Principal bei University of Louisville
Profil
Fred J.
Roisen is the founder of RhinoCyte, Inc. which was founded in 2005.
He held the title of President & Chief Executive Officer from 2009 to 2013.
Currently, he is a Professor at the University of Louisville since 1986.
Dr. Roisen has an undergraduate degree from Northeastern University and graduate and doctorate degrees from Princeton University.
Aktive Positionen von Fred J. Roisen
| Unternehmen | Position | Beginn |
|---|---|---|
| University of Louisville | Corporate Officer/Principal | 01.01.1986 |
Ehemalige bekannte Positionen von Fred J. Roisen
| Unternehmen | Position | Ende |
|---|---|---|
RhinoCyte, Inc.
 RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY. | Gründer | - |
Ausbildung von Fred J. Roisen
| Princeton University | Doctorate Degree |
| Northeastern University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
RhinoCyte, Inc.
RhinoCyte, Inc. Medical SpecialtiesHealth Technology RhinoCyte, Inc. develops and commercializes diagnostic tools and therapies. The firm engages in the discovery and development of products to extend and enhance the quality of human life. Its technology facilitates functional recovery in patients, including therapeutic stem cell transplantation with cells from the patient's own nasal cavity eliminating the need for immunosuppressive therapy. The company was founded by Fred J. Roisen and Steven R. Gailar in 2005 and is headquartered in Louisville, KY. | Health Technology |